Naoko Okada Selected Research

Naoko Okada Research Topics

Disease

14	Inflammation (Inflammations) 01/2021 - 10/2005
6	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2023 - 11/2005
6	Keratoconjunctivitis 09/2020 - 08/2009
4	Neoplasms (Cancer) 01/2018 - 04/2005
3	Conjunctival Diseases 12/2021 - 01/2008
3	Eosinophilia 01/2018 - 11/2016
3	Asthma (Bronchial Asthma) 01/2018 - 12/2013
2	COVID-19 02/2023 - 12/2020
2	Nasal Polyps (Nasal Polyp) 06/2019 - 12/2013
2	Stomach Neoplasms (Stomach Cancer) 11/2009 - 10/2009
2	Ulcer 11/2005 - 10/2005
1	Infections 12/2023
1	Human Influenza (Influenza) 02/2023
1	Necrosis 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2020
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2020
1	Cough 12/2020
1	Fever (Fevers) 12/2020
1	Lymphoma (Lymphomas) 12/2020
1	Pruritus (Itching) 09/2020
1	Rare Diseases (Rare Disease) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Aortic Dissection 10/2017
1	Aortic Diseases 10/2017
1	Airway Remodeling 07/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 04/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Eosinophilic Esophagitis 01/2017
1	Conjunctivitis 01/2016
1	Corneal Injuries 01/2016
1	Eosinophilic enteropathy 01/2016

Drug/Important Bio-Agent (IBA)

4	Tacrolimus (Prograf)FDA LinkGeneric 01/2023 - 01/2019
4	Interleukin-4 (Interleukin 4)IBA 04/2020 - 01/2008
4	ChemokinesIBA 01/2020 - 12/2009
4	Messenger RNA (mRNA)IBA 01/2013 - 10/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	Interleukin-13IBA 01/2019 - 04/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 04/2005
2	PeriostinIBA 12/2021 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2008
2	Dinoprostone (PGE2)FDA Link 01/2021 - 04/2020
2	InterleukinsIBA 01/2021 - 04/2005
2	LactoferrinIBA 09/2020 - 01/2012
2	SuspensionsIBA 09/2020 - 01/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 04/2017
2	CytokinesIBA 06/2019 - 07/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 04/2005
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 11/2016
2	Interleukin-33IBA 11/2016 - 01/2016
2	Prostaglandin D2IBA 08/2013 - 11/2005
2	Coloring Agents (Dyes)IBA 11/2005 - 10/2005
2	MucinsIBA 11/2005 - 10/2005
1	Serine Proteases (Serine Protease)IBA 12/2023
1	Angiotensin-Converting Enzyme 2IBA 12/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2023
1	Betamethasone (Celestone)FDA Link 12/2021
1	Ophthalmic Solutions (Eye Drops)IBA 01/2021
1	Ketotifen (Ketotifene)FDA Link 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 12/2020
1	favipiravirIBA 12/2020
1	mogamulizumabIBA 12/2020
1	AntipyreticsIBA 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	C-Reactive ProteinIBA 12/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Vincristine (Oncovin)FDA LinkGeneric 12/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2020
1	ProstaglandinsIBA 04/2020
1	SteroidsIBA 01/2019
1	EnzymesIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2018
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2018
1	CateninsIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	OvalbuminIBA 01/2018
1	ChitinIBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	AllergensIBA 01/2018
1	AntigensIBA 01/2018
1	Cyclin D1IBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Peptide Hydrolases (Proteases)FDA Link 07/2017
1	Extracellular Matrix ProteinsIBA 07/2017
1	palmitoleic acidIBA 04/2017
1	CollagenIBA 01/2017
1	matrigelIBA 01/2017
1	Proton Pump InhibitorsIBA 01/2017
1	lysophosphatidic acidIBA 01/2017
1	PapainIBA 11/2016
1	Thymic Stromal LymphopoietinIBA 01/2016

Therapy/Procedure

2	Therapeutics 12/2020 - 11/2009
1	Oral Administration 04/2017
1	Intranasal Administration 11/2016